Number of Shares
523.00
Current Holdings Value*
$245,140.00
% of Portfolio
1.7%
Total Estimate Gain
$208,099.80
% of Total Estimate Gain
45.92%

AXS Alternative Value Fund's Vertex Pharmaceuticals Inc Holding Summary

As of 2024-06-30, Investment Managers Series Trust II held 523.00 shares of Vertex Pharmaceuticals Inc(VRTX), totaling $245,140.00. This investment constitutes 1.7% of their stock portfolio, and Investment Managers Series Trust II now holds 0% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.

The initial trade took place in 2021Q1. And since then AXS Alternative Value Fund has made 6 purchases of VRTX, at an average price of $255.00, for a total of 1,777.00 shares. In addition, there have been 5 sales at an average price of $338.72 for 1,254.00 shares. Based on historical transaction data and VRTX's current price of $452.16, AXS Alternative Value Fund's estimated gain on his VRTX holdings is $208,099.80, reflecting a 45.92% gain to date.

AXS Alternative Value Fund VRTX ($452.16) Holding Chart

AXS Alternative Value Fund VRTX ($452.16) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1